title: Is Ondansetron Augmentation Effective in Obsessive-Compulsive Disorder?
authors.affiliation: OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India; North West Area Mental Health Service, Victoria, Australia. adityahegde@outlook.com; OCD Clinic, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
authors.forename: Bangalore G
authors.initials: BG
authors.lastname: Kalyani
authors.forename: Aditya
authors.initials: A
authors.lastname: Hegde
authors.forename: Shyam Sundar
authors.initials: SS
authors.lastname: Arumugham
authors.forename: Janardhanan C
authors.initials: JC
authors.lastname: Narayanaswamy
authors.forename: Suresh Bada
authors.initials: SB
authors.lastname: Math
authors.forename: Y C Janardhan
authors.initials: YCJ
authors.lastname: Reddy
mesh_terms: D004359:Drug Therapy, Combination; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D017294:Ondansetron / Q000008:administration & dosage / Q000494:pharmacology*; D017063:Outcome Assessment, Health Care; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*
chemical_list: D017294:Ondansetron; D058831:Serotonin 5-HT3 Receptor Antagonists; D017367:Selective Serotonin Reuptake Inhibitors